149 related articles for article (PubMed ID: 36103959)
1. Metformin, pioglitazone, dapagliflozin and their combinations ameliorate manifestations associated with NAFLD in rats via anti-inflammatory, anti-fibrotic, anti-oxidant and anti-apoptotic mechanisms.
Shaaban HH; Alzaim I; El-Mallah A; Aly RG; El-Yazbi AF; Wahid A
Life Sci; 2022 Nov; 308():120956. PubMed ID: 36103959
[TBL] [Abstract][Full Text] [Related]
2. Comparative effectiveness of phosphodiesterase 3, 4, and 5 inhibitors in amelioration of high-fat diet-induced nonalcoholic fatty liver in rats.
El-Deen RM; Heeba GH; Abdel-Latif RG; Khalifa MMA
Fundam Clin Pharmacol; 2020 Jun; 34(3):353-364. PubMed ID: 31885103
[TBL] [Abstract][Full Text] [Related]
3. NLRP3 inhibitor glibenclamide attenuates high-fat diet and streptozotocin-induced non-alcoholic fatty liver disease in rat: studies on oxidative stress, inflammation, DNA damage and insulin signalling pathway.
Dwivedi DK; Jena GB
Naunyn Schmiedebergs Arch Pharmacol; 2020 Apr; 393(4):705-716. PubMed ID: 31834465
[TBL] [Abstract][Full Text] [Related]
4. Biochemical and histological characterisation of an experimental rodent model of non-alcoholic steatohepatitis - Effects of a peroxisome proliferator-activated receptor gamma (PPAR-γ) agonist and a glucagon-like peptide-1 analogue.
Daniels SJ; Leeming DJ; Detlefsen S; Bruun MF; Hjuler ST; Henriksen K; Hein P; Karsdal MA; Brockbank S; Cruwys S
Biomed Pharmacother; 2019 Mar; 111():926-933. PubMed ID: 30841472
[TBL] [Abstract][Full Text] [Related]
5. The role of pioglitazone in antioxidant, anti-inflammatory, and insulin sensitivity in a high fat-carbohydrate diet-induced rat model of insulin resistance.
Al-Muzafar HM; Alshehri FS; Amin KA
Braz J Med Biol Res; 2021; 54(8):e10782. PubMed ID: 34037093
[TBL] [Abstract][Full Text] [Related]
6. Dapagliflozin not only improves hepatic injury and pancreatic endoplasmic reticulum stress, but also induces hepatic gluconeogenic enzymes expression in obese rats.
Swe MT; Thongnak L; Jaikumkao K; Pongchaidecha A; Chatsudthipong V; Lungkaphin A
Clin Sci (Lond); 2019 Dec; 133(23):2415-2430. PubMed ID: 31769484
[TBL] [Abstract][Full Text] [Related]
7. Fucoidan ameliorates steatohepatitis and insulin resistance by suppressing oxidative stress and inflammatory cytokines in experimental non-alcoholic fatty liver disease.
Heeba GH; Morsy MA
Environ Toxicol Pharmacol; 2015 Nov; 40(3):907-14. PubMed ID: 26498267
[TBL] [Abstract][Full Text] [Related]
8. Afriplex GRTTM extract attenuates hepatic steatosis in an in vitro model of NAFLD.
Gabuza K; Mabuda TI; Patel O; Khuboni N; van Aarde R; Riedel S; Sangweni NF; Windvogel S; Johnson R; Muller CJF
PLoS One; 2024; 19(4):e0297572. PubMed ID: 38630788
[TBL] [Abstract][Full Text] [Related]
9. Combined treatments with metformin and phosphodiesterase inhibitors alleviate nonalcoholic fatty liver disease in high-fat diet fed rats: a comparative study.
Heeba GH; El-Deen RM; Abdel-Latif RG; Khalifa MMA
Can J Physiol Pharmacol; 2020 Aug; 98(8):498-505. PubMed ID: 32083947
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of Sitagliptin on Nonalcoholic Fatty Liver Disease in High-fat-diet-fed Diabetic Mice.
Zhou ST; Cui W; Kong L; Yang X
Curr Med Sci; 2022 Jun; 42(3):513-519. PubMed ID: 35451807
[TBL] [Abstract][Full Text] [Related]
11. Thymoquinone alleviates nonalcoholic fatty liver disease in rats via suppression of oxidative stress, inflammation, apoptosis.
Awad AS; Abd Al Haleem EN; El-Bakly WM; Sherief MA
Naunyn Schmiedebergs Arch Pharmacol; 2016 Apr; 389(4):381-91. PubMed ID: 26753695
[TBL] [Abstract][Full Text] [Related]
12. The Glucagon-Like Peptide-1 Analogue Liraglutide Inhibits Oxidative Stress and Inflammatory Response in the Liver of Rats with Diet-Induced Non-alcoholic Fatty Liver Disease.
Gao H; Zeng Z; Zhang H; Zhou X; Guan L; Deng W; Xu L
Biol Pharm Bull; 2015; 38(5):694-702. PubMed ID: 25947915
[TBL] [Abstract][Full Text] [Related]
13. Pentoxifylline and melatonin in combination with pioglitazone ameliorate experimental non-alcoholic fatty liver disease.
Zaitone S; Hassan N; El-Orabi N; El-Awady el-S
Eur J Pharmacol; 2011 Jul; 662(1-3):70-7. PubMed ID: 21549113
[TBL] [Abstract][Full Text] [Related]
14. [Metformin prevents non-alcoholic fatty liver disease in rats: role of phospholipase A2/lysophosphatidylcholine lipoapoptosis pathway in hepatocytes].
Huang Y; Fu JF; Shi HB; Liu LR
Zhonghua Er Ke Za Zhi; 2011 Feb; 49(2):139-45. PubMed ID: 21426695
[TBL] [Abstract][Full Text] [Related]
15. The effects of metformin, pioglitazone, exenatide and exercise on fatty liver in obese diabetic rats: the role of IRS-1 and SOCS-3 molecules.
Lule KO; Akarsu E; Sayiner ZA; Lule NO; Balci SO; Demirel C; Bozdag Z; Korkmaz M; Yilmaz I
Inflammopharmacology; 2022 Feb; 30(1):243-250. PubMed ID: 35072848
[TBL] [Abstract][Full Text] [Related]
16. Combination of metformin and chlorogenic acid attenuates hepatic steatosis and inflammation in high-fat diet fed mice.
Zamani-Garmsiri F; Ghasempour G; Aliabadi M; Hashemnia SMR; Emamgholipour S; Meshkani R
IUBMB Life; 2021 Jan; 73(1):252-263. PubMed ID: 33326684
[TBL] [Abstract][Full Text] [Related]
17. Dapagliflozin improves steatohepatitis in diabetic rats via inhibition of oxidative stress and inflammation.
Hazem RM; Ibrahim AZ; Ali DA; Moustafa YM
Int Immunopharmacol; 2022 Mar; 104():108503. PubMed ID: 34998036
[TBL] [Abstract][Full Text] [Related]
18. The role of anti-diabetic drugs in NAFLD. Have we found the Holy Grail? A narrative review.
Zachou M; Flevari P; Nasiri-Ansari N; Varytimiadis C; Kalaitzakis E; Kassi E; Androutsakos T
Eur J Clin Pharmacol; 2024 Jan; 80(1):127-150. PubMed ID: 37938366
[TBL] [Abstract][Full Text] [Related]
19. Protective effect of boswellic acids versus pioglitazone in a rat model of diet-induced non-alcoholic fatty liver disease: influence on insulin resistance and energy expenditure.
Zaitone SA; Barakat BM; Bilasy SE; Fawzy MS; Abdelaziz EZ; Farag NE
Naunyn Schmiedebergs Arch Pharmacol; 2015 Jun; 388(6):587-600. PubMed ID: 25708949
[TBL] [Abstract][Full Text] [Related]
20. Hesperetin ameliorates hepatic oxidative stress and inflammation
Li J; Wang T; Liu P; Yang F; Wang X; Zheng W; Sun W
Food Funct; 2021 May; 12(9):3898-3918. PubMed ID: 33977953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]